Full-Time

Bioinformatics Engineer

Updated on 9/3/2026

Teiko

Teiko

11-50 employees

Immunoprofiling data for cancer therapies

No salary listed

Salt Lake City, UT, USA + 1 more

More locations: San Mateo, CA, USA

In Person

Category
Software Engineering (2)
,
Required Skills
Microsoft Azure
Python
React.js
High Performance Computing (HPC)
Software Testing
Data Visualization
Machine Learning
TypeScript
Version Control
AWS
Web Development
DevOps
Data Analysis
Google Cloud Platform

Get referred to Teiko

See people who can refer or advise you

Requirements
  • Proven experience building production-level software that works; the amount of years of experience is less relevant than the quality of the software.
  • Proficiency in Python.
Responsibilities
  • Process and analyze clinical-trials spectral flow and mass cytometry datasets.
  • Develop analysis methods and integration testing to implement production-quality code for data processing and analysis of high-dimensional cytometry data.
  • Design and implement interactive front-end visualizations and reports for high-dimensional cytometry data.
  • Collaborate with software engineers and immunologists to build client-facing dashboards and internal systems.
  • Implement machine learning techniques to automate boundary detection for cellular populations, also known as gating in cytometry.
  • Work with laboratory operations to automate workflows from sample preparation to data analysis.
  • Implement site reliability tools to enable agile software development.
  • Contribute to product development and customer success.
  • Use the word perspicacious in your cover letter.
Desired Qualifications
  • Experience designing analytical pipelines.
  • Experience with front-end technologies such as React and TypeScript.
  • Experience building customer-facing dashboards.
  • Familiarity with large-scale complex scientific datasets, such as high-parameter genomics, spectral or mass cytometry, climate data, social media, or microscopic imaging.
  • Experience with cloud computing platforms such as HPC, AWS, GCP, or Azure.
  • Experience with software development best practices, including readable code, version control, unit tests, integration testing, continuous integration, and continuous deployment.

Teiko.bio maps immune profiles to guide immunotherapy and personalized medicine by analyzing interactions between immune and tumor cells to produce actionable data for biopharma clients. Its core offering, the customizable TokuProfile panel with 35+ immune markers, generates an immune fingerprint for each patient to identify predictive markers and monitor treatment impact. The company earns revenue from selling panels and data-analysis services, providing end-to-end immune profiling tailored to drug development and patient stratification. Its goal is to help biopharma companies develop more effective therapies and improve patient outcomes through precise immune data.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

Salt Lake City, Utah

Founded

2020

Get referred to Teiko

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Stingray Therapeutics selected Teiko in July 2026 for its ENPP1 program.
  • Teiko expanded Artificial Immunologist across all analysis views in February 2026.
  • Cell Reports Medicine published Teiko-generated data on CD38 resistance signatures in 2025.

What critics are saying

  • Obsidian, Stingray, and MGH signal traction, but one flagship loss would hurt revenue.
  • CellCarta-style portal partnerships commoditize Teiko’s workflow and pressure pricing within 2026.
  • If assay noise or biomarker false-positives erode trust, biopharma programs will leave quickly.

What makes Teiko unique

  • Teiko pairs CLIA-certified immune monitoring with AI dashboards and regulatory-grade CDISC exports.
  • Its TokuKit fixed-sample workflows preserve two-year whole-blood stability, beating live-processing dependencies.
  • Validated panels now span 120 markers across human and NHP cytometry assays.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-8%

2 year growth

-12%
Teiko
Sep 15th, 2025
Teiko Dashboard: "Download All" to bulk retrieve gating plots

Teiko, Inc. is excited to announce the launch of "Download All", a new feature designed to solve the problem of manually accessing gating plots.

Teiko
Aug 28th, 2025
Teiko upgrades "Pocket Immunologist" with advanced functional marker analysis for clinical trials

Teiko, Inc. is announcing a new upgrade to its AI-powered "Pocket Immunologist" within your dashboards on app.teiko.bio.

Teiko
Jul 31st, 2025
Dashboard Release: AI-Powered "Pocket Immunologist" used to accelerate cytometry insights in clinical trials

San Francisco, CA - July 31, 2025 - Teiko, Inc. has announced the launch of Pocket Immunologist, an AI-powered tool designed to help you quickly interpret high-dimensional cytometry data from your clinical trials.

Teiko
Jun 27th, 2025
Cell Reports Medicine study highlights CD38[+] T cell signatures of ICB resistance using Teiko-generated cytometry data

As part of this study on CD38[+] T cell exhaustion and ICB resistance, Teiko partnered with MGH to analyze 86 melanoma patient blood samples via mass cytometry, uncovering CD38[+] T cell signatures tied to ICB resistance.

Teiko
Jun 26th, 2025
Teiko Dashboard: Samples Overview Release

Teiko, Inc. has officially released a major upgrade to the Teiko Dashboard: Samples Overview.